Skip to main content
Soumya Raychaudhuri, MD, Rheumatology, Boston, MA

Soumya Raychaudhuri MD PhD


Professor of Medicine, Harvard Medical School. JS Coblyn and MB Brenner Distinguished Chair, Brigham & Women's Hospital

Join to View Full Profile
  • Brigham Womens Hospital75 Francis Street PBBB3Boston, MA 02115

  • Phone+1 617-732-5325

  • Fax+1 617-525-4488

Dr. Raychaudhuri is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

Education & Training

  • Mass General Brigham/Brigham and Women's Hospital
    Mass General Brigham/Brigham and Women's HospitalFellowship, Rheumatology, 2006 - 2010
  • Mass General Brigham/Brigham and Women's Hospital
    Mass General Brigham/Brigham and Women's HospitalResidency, Internal Medicine, 2004 - 2006
  • Stanford University School of Medicine
    Stanford University School of MedicineClass of 2004

Certifications & Licensure

  • MA State Medical License
    MA State Medical License 2006 - 2025
  • Rheumatology
    American Board of Internal Medicine Rheumatology

Awards, Honors, & Recognition

  • Fellow (FACR) American College of Rheumatology

Publications & Presentations

PubMed

Journal Articles

  • High-Throughput Identification of Noncoding Functional SNPs via Type IIS Enzyme Restriction  
    Soumya Raychaudhuri, Jing Cui, Michael B Brenner, Peter A Nigrovic, Nature
  • Methods for High-Dimensonal Analysis of Cells Dissociated from Cyropreserved Synovial Tissue  
    Paul J Utz, William H Robinson, Ellen M Gravallese, Soumya Raychaudhuri, Alessandra B Pernis, Susan M Goodman, Michael B Brenner, Lionel B Ivashkiv, Brendan F Boyce, P..., BioMed Central

Other

Authored Content

  • RNA Identification of PRIME Cells Predicting Rheumatoid Arthritis FlaresJuly 2020
  • RNA Identification of PRIME Cells Predicting Rheumatoid Arthritis FlaresJuly 2020

Press Mentions

  • Mestag Therapeutics Launches with $11m for Fibroblast Goal
    Mestag Therapeutics Launches with $11m for Fibroblast GoalApril 30th, 2021
  • Newborn Bio Business Mestag Therapeutics Raises $11m Seed Cash
    Newborn Bio Business Mestag Therapeutics Raises $11m Seed CashApril 26th, 2021
  • Mestag Therapeutics Launches with Seed Financing of $11 Million to Develop Therapeutics Targeting Activated Fibroblast Populations Across Inflammatory Disease and Cancer
    Mestag Therapeutics Launches with Seed Financing of $11 Million to Develop Therapeutics Targeting Activated Fibroblast Populations Across Inflammatory Disease and CancerApril 20th, 2021
  • Join now to see all

Grant Support

  • Integrative modelling of single-cell data to elucidate the genetic architecture of complex diseaseDANA-FARBER CANCER INST2024–2028
  • Integrative modelling of single-cell data to elucidate the genetic architecture of complex diseaseDANA-FARBER CANCER INST2024–2028
  • Integrative modelling of single-cell data to elucidate the genetic architecture of complex diseaseDANA-FARBER CANCER INST2024–2028
  • Integrative modelling of single-cell data to elucidate the genetic architecture of complex diseaseDANA-FARBER CANCER INST2024–2028
  • Integrative analysis of high dimensional tissue molecular data to define key biological systems in autoimmune diseases (SBC)BRIGHAM AND WOMEN'S HOSPITAL2022–2026
  • Integrative analysis of high dimensional tissue molecular data to define key biological systems in autoimmune diseases (SBC)BRIGHAM AND WOMEN'S HOSPITAL2022–2026
  • Predicting the impact of genetic variants, genes and pathways on human DiseaseBRIGHAM AND WOMEN'S HOSPITAL2021–2026
  • Predicting the impact of genetic variants, genes and pathways on human DiseaseBRIGHAM AND WOMEN'S HOSPITAL2021–2026
  • Predicting the impact of genetic variants, genes and pathways on human DiseaseBRIGHAM AND WOMEN'S HOSPITAL2021–2026
  • Predicting the impact of genetic variants, genes and pathways on human DiseaseBRIGHAM AND WOMEN'S HOSPITAL2021–2026
  • Expanded fibroblast subset drives pathology in rheumatoid arthritisBRIGHAM AND WOMEN'S HOSPITAL2015–2026
  • Expanded fibroblast subset drives pathology in rheumatoid arthritisBRIGHAM AND WOMEN'S HOSPITAL2015–2026
  • Expanded fibroblast subset drives pathology in rheumatoid arthritisBRIGHAM AND WOMEN'S HOSPITAL2015–2026
  • Expanded fibroblast subset drives pathology in rheumatoid arthritisBRIGHAM AND WOMEN'S HOSPITAL2015–2026
  • Defining the influence of RA genetic susceptibility factors on T cell antigen specificity and functional stateBRIGHAM AND WOMEN'S HOSPITAL2013–2026

Professional Memberships

Viewing the full profile is available to verified healthcare professionals only.

Find your profile and take control of your online presence: